Ye et al. (11) had shown that the gonadal adipose tissue resident CD36+ AML LSCs have altered metabolism compared to CD36− LSC and can survive by increasing the FAO driven TCA-OXPHOS to evade the chemotherapy. The gene discussed is CD36; the disease is acute myeloid leukemia.